# Miruion Co.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/miruion-co

- Industry: Healthcare
- Headquarters: Osaka, Japan
- Website: www.miruion.com
- Total disclosed funding: $0.1M
- Latest round: Series A (Jun 3, 2024)
- Investors on record: 1

## About

Founded in 2019 and based in Osaka, Japan, Miruion Co., Ltd. is a biotech venture spun out of Osaka University that operates as a mass spectrometry imaging firm. In June 2024, Miruion raised venture funding from Future Venture Capital. As of 2024, the company is led by its representative director and CEO, Kazuki Odake.

Milllion provides mass spectrometry imaging (MSI) contract analysis services. Mass spectrometry imaging is a molecular visualization technique used to visualize the distribution of molecules presented on two-dimensional sample surfaces. MSI visualizes the location, type, and quantity of molecules on a sample surface. The company offers contract analysis services that analyze various samples, including animal tissues, human clinical specimens (with specific protocols), three-dimensional model tissues (skin, tumors), plants (leaves, seeds), and food. The firm offers a hair testing service that tests various components in hair, such as sugars, and visualizes the history of various body conditions.

The company plans to use the funds raised in June 2024 to expand its market reach.

## Funding rounds

- Series A, Jun 3, 2024, $0.1M — MIRAIDOOR

## Investors

- MIRAIDOOR (https://capitalatlas.ai/funds/miraidoor) — Series A